BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19463270)

  • 1. [Micafungin, a new candin for the treatment of invasive mycoses].
    Del Palacio A; Pontón J; Quindós G
    Rev Iberoam Micol; 2009 Mar; 26(1):1. PubMed ID: 19463270
    [No Abstract]   [Full Text] [Related]  

  • 2. [Micafungin: new challenges, new possibilities in the treatment of invasive fungal infection].
    Pemán J; Torre-Cisneros J
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():1-2. PubMed ID: 21420569
    [No Abstract]   [Full Text] [Related]  

  • 3. [Invasive fungal infection in critically ill patient: role of micafungin].
    Nieto Cabrera M; López-Cepero EE
    Rev Esp Quimioter; 2012 Mar; 25(1):4-9. PubMed ID: 22488535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micafungin therapy in a critically ill, morbidly obese patient.
    Zomp A; Bookstaver PB; Ahmed Y; Turner JE; King C
    J Antimicrob Chemother; 2011 Nov; 66(11):2678-80. PubMed ID: 21810839
    [No Abstract]   [Full Text] [Related]  

  • 5. Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases.
    Cornely OA; Pappas PG; Young JA; Maddison P; Ullmann AJ
    Expert Opin Drug Saf; 2011 Mar; 10(2):171-83. PubMed ID: 21306282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micafungin (Mycamine) for fungal infections.
    Med Lett Drugs Ther; 2005 Jun; 47(1211):51-2. PubMed ID: 15961968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micafungin: new drug. Severe candidiasis: a third echinocandin, with life-threatening hepatotoxicity.
    Prescrire Int; 2009 Aug; 18(102):154. PubMed ID: 19743568
    [No Abstract]   [Full Text] [Related]  

  • 8. [Echinocandins in children].
    Leverger G; Le Guyader N
    Arch Pediatr; 2011 May; 18 Suppl 1():S33-41. PubMed ID: 21596285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei.
    Shorr AF; Wu C; Kothari S
    J Antimicrob Chemother; 2011 Feb; 66(2):375-80. PubMed ID: 21147825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different bile concentration of micafungin and itraconazole in a patient with candidal cholecystitis.
    Maruyama T; Takei Y; Gabazza EC; Morser J; Taguchi O
    J Infect; 2009 Apr; 58(4):315-6. PubMed ID: 19269034
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders.
    Tamura K; Urabe A; Yoshida M; Kanamaru A; Kodera Y; Okamoto S; Maesaki S; Masaoka T
    Leuk Lymphoma; 2009 Jan; 50(1):92-100. PubMed ID: 19172498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micafungin for the prophylaxis and treatment of Candida infections.
    Fritz JM; Brielmaier BD; Dubberke ER
    Expert Rev Anti Infect Ther; 2008 Apr; 6(2):153-62. PubMed ID: 18380597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial.
    Queiroz-Telles F; Berezin E; Leverger G; Freire A; van der Vyver A; Chotpitayasunondh T; Konja J; Diekmann-Berndt H; Koblinger S; Groll AH; Arrieta A;
    Pediatr Infect Dis J; 2008 Sep; 27(9):820-6. PubMed ID: 18679151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal prophylaxis with micafungin in patients treated for childhood cancer.
    Kusuki S; Hashii Y; Yoshida H; Takizawa S; Sato E; Tokimasa S; Ohta H; Ozono K
    Pediatr Blood Cancer; 2009 Oct; 53(4):605-9. PubMed ID: 19533659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micafungin: the US perspective.
    Zaas AK; Steinbach WJ
    Expert Rev Anti Infect Ther; 2005 Apr; 3(2):183-90. PubMed ID: 15918776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment recommendations for invasive fungal disease in pediatric patients with cancer or blood disease].
    Tang S; ; ; ;
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):426-9. PubMed ID: 25190161
    [No Abstract]   [Full Text] [Related]  

  • 17. Disseminated invasive aspergillosis successfully treated with micafungin in a renal transplant recipient.
    Wadi J; Al-kawasmeh SI; Kamel MT; AlJayyousi BB
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):914-8. PubMed ID: 20814131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infectious diseases: progress in diagnosis and treatment. Topics: IV. Towards containing infectious diseases: 3. Development of new antifungal drugs].
    Yoshida M
    Nihon Naika Gakkai Zasshi; 2012 Nov; 101(11):3185-91. PubMed ID: 23342592
    [No Abstract]   [Full Text] [Related]  

  • 19. [Liver toxicity of micafungin. Is this drug safe?].
    Valerio M; Muñoz P; Bouza E
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():29-32. PubMed ID: 21420574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of Candida infections in preterm neonates and the role of micafungin.
    Manzoni P; Benjamin DK; Hope W; Rizzollo S; Del Sordo P; Stronati M; Jacqz-Aigrain E; Castagnola E; Farina D
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 2():24-7. PubMed ID: 21749182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.